Publicacions
-
Vilarrubi A, Guillén G, Liu X, Navajas-Chocarro P, Morillas JM, Martínez-Romero A, Diaz CA, Pros E, Altemir-Hervas E, Ezzaanouni A, Fernández-Serrano M, Roué G, Gómez A, CastilloSD, Vidal A, Carretero J, Martínez-Iniesta M, Soriano A, Moreno L, Villanueva A, Sanchez-Cespedes M and Romero OA.
SMARCB1 Deficiency in Tumors Confers a Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption.
CANCER RESEARCH . : .
